Correction: Peroxisome proliferator-activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity [Journal Experimental Medicine, 204, 2, (2007)] DOI:10.1084/jem.20061839;Peroxisome proliferator-activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell-mediated autoimmunity

Journal of Experimental Medicine

Volumn 204, Issue 2, 2007, Pages 321-330

  Dunn, Shannon E ^a   Ousman, Shalina S ^a   Sobel, Raymond A ^a   Zuniga, Luis ^a   Baranzini, Sergio E ^b   Youssef, Sawsan ^a   Crowell, Andrea ^a   Loh, John ^a   Oksenberg, Jorge ^b   Steinman, Lawrence ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 27; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN C JUN; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANDROGEN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE;

EID: 33847161302     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.2006183905142018c     Document Type: Erratum

References (55)

1. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
2. Noseworthy, J.H., C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343:938-952.
3. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:500-508.
4. Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
5. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177:566-573.
6. Panitch, H.S., R.L. Hirsch, J. Schindler, and K.P. Johnson. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 37:1097-1102.
7. Racke, M.K., A. Bonomo, D.E. Scott, B. Cannella, A. Levine, C.S. Raine, E.M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961-1966.
8. Navikas, V., and H. Link. 1996. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:322-333.
9. Beeson, P.B. 1994. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 96:457-462.
10. Whitacre, C.C., S.C. Reingold, and P.A. O'Looney. 1999. A gender gap in autoimmunity. Science. 283:1277-1278.
11. Lichtman, M.A., J.H. Vaughan, and C.G. Hames. 1967. The distribution of serum immunoglobulins, anti-gamma-G globulins ("rheumatoid factors") and antinuclear antibodies in White and Negro subjects in Evans County, Georgia. Arthritis Rheum. 10:204-215.
12. Amadori, A., R. Zamarchi, G. De Silvestro, G. Forza, G. Cavatton, G.A. Danieli, M. Clementi, and L. Cheico-Bianchi. 1995. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1:1279-1283.
13. Pelfrey, C., A. Cotleur, J.-C. Lee, and R.A. Rudick. 2002. Sex differences in cytokine responses to myein peptides in multiple sclerosis. J. Neuroimmunol. 130:211-213.
14. Barna, M., T. Komatsu, Z. Bi, and C.S. Reiss. 1996. Sex differences in susceptibility to viral infection of the central nervous system. J. Neuroimmunol. 67:31-39.
15. Fuller, A.C., B. Kang, H.K. Kang, H. Yahikozowa, M.C. Dal Canto, and B.S. Kim. 2005. Gender bias in Theiler's virus-induced demyelinating disease correlates with the level of anti-viral immune responses. J. Immunol. 175:3955-3963.
16. Han, X., P. Lundberg, B. Tanamachi, H. Openshaw, J. Longmate, and E. Cantin. 2001. Gender influences herpes simplex virus type 1 infection in normal and interferon-mutant mice. J. Virol. 75:3048-3052.
17. Voskuhl, R.R., and K. Palszynski. 2001. Sex hormones in experimental autoimmune encephomyelitis: implications for multiple sclerosis. Neuroscientist. 7:258-270.
18. Palaszynski, K.M., K.K. Loo, J.F. Ashouri, H.B. Lu, and R.R. Voskuhl. 2004. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146:144-152.
19. Roubinian, J.R., N. Talal, J.S. Greenspan, J.R. Goodman, and R.P. Siiteri. 1978. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 147:1568-1583.
20. Fox, H.S. 1992. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 175:1409-1412.
21. Dalal, M., S. Kim, and R. Voskuhl. 1997. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159:3-6.
22. Bebo, B.F., Jr., J.C. Schuster, A.A. Vandenbark, and H. Offner. 1999. Androgens alter the cytokine profile and reduce encephalogenicity of myelin-reactive T cells. J. Immunol. 162:35-40.
23. Wei, T., and S.L. Lightman. 1997. The neuroendocrine axis in patients with multiple sclerosis. Brain. 120:1067-1076.
24. Foster, S.C., C. Daniels, D.N. Bourdette, and B.F. Bebo Jr. 2003. Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 140:78-87.
25. Cutolo, M., E. Balleari, M. Giusti, E. Intra, and S. Accardo. 1991. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34:1-5.
26. Liva, S.M., and R.R. Voskuhl. 2001. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167:2060-2067.
27. Daynes, R.A., and D.C. Jones. 2002. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2:748-759.
28. Barbier, O., I.P. Torra, Y. Duguay, C. Blanquart, J.C. Fruchart, C. Glineur, and B. Staels. 2002. Pleiotropic actions of peroxisome proliferators-activated receptors in lipid metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22:717-726.
29. Delerive, P., K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, F.J. Gonzalez, J.C. Fruchart, A. Tedgui, G. Haegeman, and B. Staels. 1999. Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J. Biol. Chem. 274:32048-32054.
30. Jalouli, M., L. Carlsson, C. Ameen, D. Linden, A. Ljungberg, L. Michalik, S. Eden, W. Wahli, and J. Oscarsson. 2003. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology. 144:101-109.
31. Hawkins, J.M., W.E. Jones, F.W. Bonner, and G.G. Gibson. 1987. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev. 18:441-515.
32. Kawashima, Y., N. Uy-Yu, and H. Kozuka. 1989. Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol. Biochem. J. 263:897-904.
33. Djouadi, F., C.J. Weinheimer, J.E. Saffitz, C. Pitchford, J. Bastin, F.J. Gonzalez, and D.P. Kelly. 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor alpha-deficient mice. J. Clin. Invest. 102:1083-1091.
34. Schachtrup, C., T.E. Scholzen, V. Grau, T.A. Luger, C. Sorg, F. Spener, and C. Kerkhoff. 2004. L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: evidence for a PPARalpha-independent mechanism. Int. J. Biochem. Cell Biol. 36:2042-2053.
35. Dong, C., R.J. Davis, and R.A. Flavell. 2001. Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase. J. Clin. Immunol. 21:253-257.
36. Nakahira, M., H.J. Ahn, W.R. Park, P. Gao, M. Tomura, C.S. Park, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara. 2002. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168:1146-1153.
37. Kane, L.P., J. Lin, and A. Weiss. 2002. It's all rel-ative: NF-kappaB and CD28 costimulation in T-cell activation. Trends Immunol. 23:413-420.
38. Lovett-Racke, A.E., R.Z. Hussain, S. Northrop, J. Choy, A. Rocchini, L. Matthes, J.A. Chavis, A. Diab, P.D. Drew, and M.K. Racke. 2004. Peroxisome proliferators-activated receptor ? agonists as therapy for autoimmune disease. J. Immunol. 172:5790-5798.
39. Badou, A., M. Savignac, M. Moreau, C. Leclerc, G. Foucras, G. Cassar, P. Paulet, D. Lagrange, P. Druet, J.C. Guery, and L. Pelletier. 2001. Weak TCR stimulation induces a calcium signal that triggers IL-4 synthesis, stronger TCR stimulation induces MAP kinases that control IFN-γ production. Eur. J. Immunol. 31:2487-2496.
40. Jorritsma, P.J., J.L. Brogdon, and K. Bottomly. 2003. Role of TCR-induced extracellular signal-related kinase activation in the regulation of early IL-4 expression in naïve CD4+ cells. J. Immunol. 170:2427-2434.
41. Park, H., Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
42. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
43. Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadorkoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121-1133.
44. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006. Reciprical developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238.
45. Forman, B.M., J. Chen, and R.M. Evans. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94:4312-4317.
46. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649-688.
47. Guzman, M., J. Lo Verme, J. Fu, F. Oveisi, C. Blazquez, and D. Piomelli. 2004. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279:27849-27854.
48. Jones, D.C., X. Ding, T.Y. Zhang, and R.A. Daynes. 2003. Peroxisome proliferators-activated receptor negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation. J. Immunol. 171:196-203.
49. Rincon, M., and R.A. Flavell. 1999. Reprogramming transcription during the differentiation of precursor CD4+ cells into effector Th1 and Th2 cells. Microbes Infect. 1:43-50.
50. Tai, E.S., A. bin Ali, Q. Zhang, L.M. Loh, C.E. Tan, L. Retnam, R.M. El Oakley, and S.K. Lim. 2003. Hepatic expression of PPARalpha, a molecular target of fibrates, is regulated during inflammation in a gender-specific manner. FEBS Lett. 546:237-240.
51. Wilcoxen, S.C., E. Kirkman, K.C. Dowdell, and S.A. Stohlman. 2000. Gender-dependent IL-12 secretion by APC is regulated by IL-10. J. Immunol. 164:6237-6243.
52. Reddy, J., H. Waldner, Z. Illes, K.W. Wucherpfennig, R.A. Sobel, and V.K. Kuchroo. 2005. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175:5591-5595.
53. Sanna, V., A. Di Giacoma, A. La Cava, R.I. Lechler, S. Fontana, S. Zappacosta, and G. Matarese. 2003. Leptin surge precedes onset of experimental autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111:241-250.
54. Palaszynski, K.M., D.L. Smith, S. Kamrava, P.S. Burgoyne, A.P. Arnold, and R.R. Voskuhl. 2005. A ying-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology. 146:3280-3285.
55. Pedotti, R., J.J. DeVoss, S. Youssef, D. Mitchell, J. Wedemeyer, R. Madanat, H. Garren, P. Fontoura, M. Tsai, S.J. Galli, et al. 2003. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA. 100:1867-1872.